CoChat

Creatine supplementation in women's health: a lifespan perspective

Open access
Smith-Ryan, Abbie E, Cabre, Hannah E, Eckerson, Joan M, Candow, Darren G · 2021 · Nutrients

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index; 5 of the 70 sources its claims cite were checked for support.

Abstract

Despite extensive research on creatine, evidence for use among females is understudied. Creatine characteristics vary between males and females, with females exhibiting 70–80% lower endogenous creatine stores compared to males. Understanding creatine metabolism pre- and post-menopause yields important implications for creatine supplementation for performance and health among females. Due to the hormone-related changes to creatine kinetics and phosphocreatine resynthesis, supplementation may be particularly important during menses, pregnancy, post-partum, during and post-menopause. Creatine supplementation among pre-menopausal females appears to be effective for improving strength and exercise performance. Post-menopausal females may also experience benefits in skeletal muscle size and function when consuming high doses of creatine (0.3 g·kg−1·d−1); and favorable effects on bone when combined with resistance training. Pre-clinical and clinical evidence indicates positive effects from creatine supplementation on mood and cognition, possibly by restoring brain energy levels and homeostasis. Creatine supplementation may be even more effective for females by supporting a pro-energetic environment in the brain. The purpose of this review was to highlight the use of creatine in females across the lifespan with particular emphasis on performance, body composition, mood, and dosing strategies.

Overview

CoChat Summary

TL;DR

This narrative review synthesizes evidence on creatine supplementation in females across the lifespan, focusing on performance, body composition, mood, cognition, and dosing. It concludes that creatine is generally safe and may offer particular benefits during hormonal transitions, but female-specific and long-term data remain limited.

Key findings

  • Females exhibit 70–80% lower endogenous creatine stores than males; premenopausal creatine supplementation improves strength and power without marked body-weight changes. For example, 10 weeks of creatine monohydrate (CrM) increased 1RM leg press, leg extension, and squat by 20–25% more than placebo, and in female soccer players increased bench press and squat 1RM by 18% and 24% versus 9% and 12% with placebo.
  • Postmenopausal females may benefit from short-term high-dose creatine (0.3 g·kg−1·d−1 or ~20 g·d−1 for 7 days), which augmented whole-body fat-free mass (0.52 ± 0.05 kg), leg press strength (5.2 ± 1.8 kg), bench press strength (1.7 ± 0.4 kg), and sit-stand/tandem gait performance. Combined with resistance training, CrM (≥5 g·d−1) generally improved muscle accretion, strength, and physical function, though bone effects were mixed or absent.
  • Mood and cognition evidence includes a decline in mean Children’s Depression Rating Scale-Revised score from 69 to 30.6 (56% decrease) in adolescent females taking 4 g CrM daily for 8 weeks with antidepressants, and greater Hamilton Depression Rating Scale improvements after 2 weeks with 5 g·d−1 for 8 weeks. Adults in the lowest quartile of dietary creatine intake had a 31% greater incidence of depression.
  • Dosing: a loading phase increases total muscle creatine concentrations by 19% in females; 0.3 g·kg−1·d−1 for 5–7 days or 5 g·d−1 for 4 weeks can be effective, while brain saturation may require 15–20 g·d−1 for 3–7 days followed by 5–10 g·d−1.

Methods

  • Narrative review of creatine supplementation in females from young adulthood to old age, with no new primary data collection.
  • Synthesizes human trials and preclinical/animal evidence on exercise performance, body composition, pregnancy, post-menopause, mood, cognition/sleep, and dosing strategies.
  • Includes relative-effect calculations from cited studies using the equation RE = ((PostCr/PreCr) × 100 / (PostPL/PrePL) × 100) × 100, where values >100 indicate improvement with creatine.

Limitations

  • Stated: female-specific evidence is understudied; there are no human studies evaluating CrM supplementation during pregnancy; individual variability (responders, quasi-responders, non-responders) has not yet been explored in females; future longer-term randomized placebo-controlled trials with large sample sizes are needed for musculoskeletal outcomes.
  • Stated in cited studies: some trials lacked a placebo group, had non-responders, used insufficient loading doses or training volumes, or enrolled participants with higher baseline intramuscular creatine; not all studies show additive effects of CrM on strength or body composition.
  • Evident: as a narrative review, no systematic search strategy, risk-of-bias assessment, or meta-analysis is described, and conclusions rely on heterogeneous studies plus extrapolation from animal and preclinical data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu13030877

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 A theoretical model for the interplay between creatine kinase and menstrual cycle hormones [6,10,11]. Creatine metabolism and creatine kinase concentrations vary throughout the menstrual cycle and lifecycle. These alterations may also influence metabolic characteristics of protein and carbohydrate oxidation [12], which provides a physiological basis for the potential use of creatine supplementation for females.
Figure 1 A theoretical model for the interplay between creatine kinase and menstrual cycle hormones [6,10,11]. Creatine metabolism and creatine kinase concentrations vary throughout the menstrual cycle and lifecycle. These alterations may also influence metabolic characteristics of protein and carbohydrate oxidation [12], which provides a physiological basis for the potential use of creatine supplementation for females.CC BY · PubMed Central
Figure 2 The relative effects of creatine supplementation in comparison to placebo for strength performance in females.
Figure 2 The relative effects of creatine supplementation in comparison to placebo for strength performance in females.CC BY · PubMed Central
Figure 3 The relative effects of creatine supplementation in comparison to a placebo on exercise performance in females.
Figure 3 The relative effects of creatine supplementation in comparison to a placebo on exercise performance in females.CC BY · PubMed Central
Figure 4 The relative effects of creatine supplementation in comparison to placebo on sports performance in females.
Figure 4 The relative effects of creatine supplementation in comparison to placebo on sports performance in females.CC BY · PubMed Central

Verification

Claims the paper makes

3 Valid · 4 Not valid · 56 Not checked · 31 Own results and interpretations

57 more claims

Create a free account to see all 94 claims and to verify the 64 references still open.

See all claims — free account
  • It may state two separate claims as one. 25
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 113 references

Research works printed but not linked: 1

  1. Selsby, 2003, Swim performance following creatine supplementation in Division III athletes, J. Strength Cond. Res., 17, 421

Cited by

Metadata

Authors
Smith-Ryan, A. E., Cabre, H. E., Eckerson, J. M., & Candow, D. G.
Affiliations
  • Applied Physiology Laboratory, Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27713, USA
  • University of North Carolina at Chapel Hill (US)
  • Creighton University (US)
  • University of Regina (CA)
Venue
Nutrients
Publisher
MDPI AG
Published
2021-03-08
Volume
13
Issue
3
Pages
877
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3135692987
Cited by
92
References
112
Citations by year
2026: 26 · 2025: 21 · 2024: 18 · 2023: 13 · 2022: 11 · 2021: 3
FWCI
1.42
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
Keywords
creatine supplementation, women's health, sex differences, menopause, phosphocreatine resynthesis, exercise performance, resistance training, postpartum period, pregnancy, bone health, mood, cognition, brain energy metabolism, body composition
MeSH terms
Adult, Affect, Aged, Body Composition, Brain, Creatine, Female, Humans, Longevity, Menopause, Middle Aged, Phosphocreatine, Exercise, Women's Health, Muscle, Skeletal, Dietary Supplements, Resistance Training

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.